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Available online 20 December 2016Heterozygous and rare homozygous mutations in PRoline-Rich Transmembrane protein 2 (PRRT2) underlie a
group of paroxysmal disorders including epilepsy, kinesigenic dyskinesia episodic ataxia and migraine. Most of
the mutations lead to impaired PRRT2 expression and/or function. Recently, an important role for PRTT2 in the
neurotransmitter release machinery, brain development and synapse formation has been uncovered. In this
work, we have characterized the phenotype of a mouse in which the PRRT2 gene has been constitutively
inactivated (PRRT2 KO). β-galactosidase staining allowed to map the regional expression of PRRT2 that was
more intense in the cerebellum, hindbrain and spinal cord, while it was localized to restricted areas in the fore-
brain. PRRT2 KO mice are normal at birth, but display paroxysmal movements at the onset of locomotion that
persist in the adulthood. In addition, adult PRRT2 KO mice present abnormal motor behaviors characterized by
wild running and jumping in response to audiogenic stimuli that are ineffective in wild type mice and an in-
creased sensitivity to the convulsive effects of pentylentetrazol. Patch-clamp electrophysiology in hippocampal
and cerebellar slices revealed specific effects in the cerebellum, where PRRT2 is highly expressed, consisting in
a higher excitatory strength at parallelfiber-Purkinje cell synapses during high frequency stimulation. The results
show that the PRRT2 KOmouse reproduces themotor paroxysms present in the human PRRT2-linked pathology
and can be proposed as an experimentalmodel for the study of the pathogenesis of the disease as well as for test-
ing personalized therapeutic approaches.
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. This is an open access article undergrouped in three major phenotypes: Benign Familial Infantile Epilepsy
(BFIE), Paroxysmal Kinesigenic Dyskinesia (PKD), and Infantile Convul-
sions with Choreoathetosis (ICCA)/Paroxysmal Kinesigenic Dyskinesia
with Infantile Convulsions (PKD/IC) (Chen et al., 2011; Lee et al., 2012).
To date, some 1500 patients with 70 different PRRT2mutations have
been reported, 78% of which carrying the same frameshift mutation
(c.649dupC). In addition to this frequent mutation, about 75% of all re-
ported PRRT2 mutations involve the insertion of a precocious stop
codon, leading to an unstable mRNA and/or a truncated protein that is
degraded or mistargeted (Chen et al., 2011; Lee et al., 2012; Li et al.,
2015; Liu et al., 2016; Valtorta et al., 2016). Of the 22 reportedmissense
mutations, 16 were not found or were found only once in N60,000
exomes, indicating the high likelihood of their pathogenicity.
The core of PRRT2-associated disorders consists of three diseases
BFIE, PKD and PKD/IC forming a continuous spectrum. PRRT2mutations
account for the majority of familial BFIE, PKD and PKD/IC patients and,
conversely, 95% of PRRT2 patients have a diagnosis within the BFIE–
PKD/IC–PKD spectrum. In addition, a low percentage (5%) of patients
bearing PRRT2 mutations display other disorders such as episodicthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ability. The noticeable pleiotropy of the phenotypes associated with
PRRT2mutations is not reflected by specific genotype-phenotype corre-
lations (Ebrahimi-Fakhari et al., 2015; Gardiner et al., 2015; Heron and
Dibbens, 2013; Valtorta et al., 2016).
In BFIE, patients exhibit afebrile seizures starting from 6 months to
about 2 years of age and including clusters of focal or generalized attacks
with normal interictal EEG and MRI (Scheffer et al., 2012; Vigevano,
2005). PKD-affected patients are characterized by short and frequent
episodes of dystonic or choreiformmovements triggered by sudden vol-
untary movements or startle with onset in childhood or adolescence
(Ebrahimi-Fakhari et al., 2015). In the ICCA syndrome, patients exhibit
infantile seizures, movement disorders or both. All the above-described
syndromes are characterized by paroxysmal attacks that occur periodi-
cally, suggesting the existence of common underlying pathophysiologi-
cal mechanisms (Valtorta et al., 2016). The few patients bearing
homozygous or compoundheterozygousmutations in PRRT2 show a se-
vere encephalopathic phenotype, with paroxysmal dyskinesias, unusu-
ally prolonged ataxia attacks, seizures and intellectual disability
(Delcourt et al., 2015; Huang et al., 2015; Labate et al., 2012). However,
until very recently, knowledge concerning the molecular mechanisms
by which PRRT2 mutations cause the disease and manifest with differ-
ent phenotypes remained scarce. The association of PRRT2-linked pa-
thologies with haploinsufficiency, as well as the more severe
phenotype of homozygousmutations, indicate that the disorders are at-
tributable to loss-of-function of the protein and gene-dosage effects and
suggest that the silencing or the constitutive deletion of the PRRT2 gene
in the mouse can be a valid model to study the pathogenesis of the
PRRT2-linked diseases.
A series of very recent papers have shown that PRRT2 is involved in
brain development, synapse formation and neurotransmitter release
(Liu et al., 2016; Valente et al., 2016). PRRT2 is a type II transmembrane
protein with a C-terminal anchor, resembling the SNARE proteins
VAMP/synaptobrevin and syntaxin (Rossi et al., 2016). In humans and
rodents, PRRT2 is neuron-specific and is expressed with the highest
levels in cerebellum, basal ganglia and neocortex. In the cortex and hip-
pocampus, PRRT2 is already expressed at early postnatal stages, a post-
natal stages, and its expression increases to reach a plateau at 1 month
of life over a period of synapse formation and rearrangement (Chen et
al., 2011; Ebrahimi-Fakhari et al., 2015; Valente et al., 2016). In neurons,
PRRT2 has a distal distribution with the highest levels at synapses,
where it mostly codistributes with proteins associated with the presyn-
aptic area and, to amuch lower extent, in fractions enriched in post-syn-
aptic densities (Lee et al., 2012; Liu et al., 2016; Valente et al., 2016).
Acute silencing of PRRT2 by RNA interference during in vitro devel-
opment was shown to cause a decrease in the density of synaptic con-
nections (Valente et al., 2016) that was paralleled in vivo by a delayed
radial migration of neurons and a decreased density of synaptic spines
(Liu et al., 2016). Interestingly, PRRT2 silencing in primary neurons
was followed by a severe impairment in synchronous release, while
the asynchronous release was relatively preserved (Valente et al.,
2016). This cellular phenotype was supported by the observation that,
at the presynaptic level, PRRT2 interacts with the fast Ca2+ sensors
synaptotagmins 1 and 2 and with SNAP25 and VAMP/synaptobrevin,
endowing the SNARE complex with Ca2+ sensitivity for fast synchro-
nous neurotransmitter release (Boyken et al., 2013; Lee et al., 2012;
Valente et al., 2016).
Here, we have for the first time characterized a genetically altered
mouse constitutively lacking PRRT2 that also allowed us to analyze
PRRT2 expression by means of a knocked-in lacZ sequence. We find
that PRRT2 is abundantly expressed in the hindbrain neurons and in re-
stricted populations of forebrain neurons. PRRT2 knockout (KO) mice
display a pleiotropic paroxysmal phenotype during infancy and in the
adulthood with paroxysmal dyskinesias in response to audiogenic
stimuli and an increased sensitivity to the convulsive effects of
pentylentetrazol (PTZ). Thus, the PRRT2 KOmouse reproduces multipleaspects of the human pathology associated with PRRT2 mutations and
can therefore be used as a reliable experimental model of PRRT2-linked
neurological disorders.
2. Materials and methods
2.1. Experimental animals and housing
Heterozygous PRRT2 KOmicewere kindly provided by the IMPC Eu-
ropean Consortium at the Sanger Institute (UK) in the frame of the Eu-
ropean EMMA/Infrafrontier, and bred at the IIT SPF animal facility. The
EUCOMM/KOMP targeting strategy was based on the “knockout-first”
allele that contains an IRES:lacZ trapping cassette and a floxed neo cas-
sette that were inserted into the intronic region among the exons 1 and
2 of the PRRT2 wild type locus (Fig. S1A). The presence of an Engrailed
(En2) splice acceptor disrupts gene function, resulting in a lacZ fusion
for studying gene expression localization (Skarnes et al., 2011).
Genotyping was performed by PCR with primers Prrt2_F:
AGGTAGACGGGCATTTGAGC, Prrt2_R: CGTGGGGAAGAGGAGACAAC;
CAS_R1_Term: TCGTGGTATCGTTATGCGCC, that were used to detect
the wild-type (WT) (Prrt2_F plus Prrt2_R product, 480 bp) and mutant
(Prrt2_F plus CAS_R1_Term product, 200 bp) PRRT2 alleles and to geno-
type WT, heterozygous (HET) and KO mice. The primer Prrt2 F is com-
mon to wild type and mutant PCR and was designed in the intronic
sequence between Prrt2 Exon 1 and Exon 2. The primer Prrt2 R was de-
signed in the exon 2 of PRRT2 gene and the Cas_R1_Termwas designed
in the targeting cassette (Fig. S1A). The colony was maintained on a
C57BL/6N background and propagated in heterozygosity. Two females
were housed with one male in standard Plexiglas cages (33 × 13 cm),
with sawdust bedding and a metal top. After two weeks of mating,
male mice were removed and dams were housed individually in Plexi-
glas cages and daily checked for delivery. Mice were maintained on a
12 ∶12 h light/dark cycle (lights on at 7 a.m.). The temperature was
maintained at 21 ± 1 °C, relative humidity (60 ± 10%). Animals were
provided drinking water and a complete pellet diet (Mucedola, Settimo
Milanese, Italy) ad libitum. Mouse genotypes were determined at
weaning (at P25) by RT-PCR on tail samples. Mice were weaned into
cages of same sex pairs. All experiments were carried out in accordance
with the guidelines established by the European Communities Council
(Directive 2010/63/EU of March 4th, 2014) and were approved by the
Italian Ministry of Health (authorization n. 73/2014-PR and n. 1276/
2015-PR).
2.2. X-gal (β-galactosidase) staining
Brains isolated from HET and PRRT2 KO mice at various postnatal
day (P) stages (P4, P8 and P16 up to 2 months of age) were fixed with
2% paraformaldehyde/0.2% glutaraldehyde solution, permeabilized in
wash buffer (1% sodium deoxycolate, 2% NP-40, MgCl2 0.1 M), included
in 2.5% agarose and cut with a microtome (Bioptica). Coronal sections
(120 μm)were incubated with X-Gal solution (X-Gal 100 mg/ml, ferro-
cyanide potassium 2 mg/ml, ferricyanide potassium 1.64 mg/ml in
Wash Buffer) for 6 h (P4, P8 mice) and overnight (P16, P60 mice) at
37 °C as previously described (Gazzerro et al., 2012). The entire slices
were acquired at 20× while higher magnifications were acquired at
40×. Sections were analyzed with Neurolucida software (Micro-
BrightField) connected to a Nikon E-800 microscope via a color CCD
camera. The identification of the specific β-gal-positive areas was per-
formed using the Paxinos mouse brain atlas (Paxinos and Franklin,
2012) and the interactive Allen Brain Explorer atlas (The Allen Institute,
http://mouse.brain-map.org/static/brainexplorer).
2.3. Western blotting
Protein concentration of the samples was determined using the BCA
assay and equivalent amounts of protein were subjected to SDS-PAGE
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branes (Whatman). Blotted membranes were blocked for 1 h in 5%
milk in Tris-buffered saline (10 mM Tris, 150 mM NaCl, pH 8.0) plus
0.1% Tween-20 and incubated overnight at 4 °C with anti-PRRT2
(1:500, Sigma-Aldrich) and anti-calnexin (1:5000, Sigma-Aldrich) poly-
clonal primary antibodies. Membranes were washed and incubated for
1 h at room temperature with peroxidase-conjugated goat anti-rabbit
(1:5000; Bio-Rad) antibodies and immunoreactive protein bands were
revealed with the ECL chemiluminescence detection system (Thermo
Scientific, Waltham, Ma, USA).
2.4. Real time PCR
Total RNA was isolated from different brain areas using QIAzol Re-
agent (QIAGEN, Ilden, D) according to the manufacturer's instructions.
The RNA yield and A260/280 ratio were quantified by using the
Nanodrop-1000 spectrophotometer (Thermo Fisher Scientific, Wal-
tham, USA). Subsequently, the samples were treated with RNase-free
DNase to remove possible traces of genomic DNA. cDNA synthesis was
then performed on 2 μg of total RNA using the GoScript reverse tran-
scription system (Promega,Madison,USA) and randomprimers, follow-
ing manufacturer's instructions and including RT- negative controls.
Real time PCR analyses were performed using the SYBR Green I Master
mix (Roche), on a CFX96 Touch Real-Time PCR Detection System
(Biorad), with the following protocol: 95 °C for 10 min; 30 s at 95 °C/
20 s at the specific annealing temperature (Ta)/30 s at 72 °C for 45 cy-
cles; melting curve (heating ramp from 55 °C to 95 °C) in order to
check for amplification specificity. The following primers (final concen-
tration 0.25 μM) and annealing temperatures were used:
PRRT2 For: CCACAATGTTGACAGGCCAC, Ta = 59.69 °C;
PRRT2 Rev: GAAGGCACCCAGAAACCTCG, Ta = 60 °C;
SNAP25 For: GCATTGAAGAAGAAACCTCGGG, Ta = 59.84 °C;
SNAP25 Rev: GGTAGCAAGAGTGGAGGAGC, Ta = 59.82 °C;
VGAT For: TGTCCTATCCGTTGCCCTTC, Ta = 59.46 °C;
VGAT Rev: CATAGCAGGCGGGGAAGAAG, Ta = 60.53 °C;
VGLUT1 (SLC17A7) For: ACTCCATACACCTCTAGCCTGA, Ta =
59.75 °C;
VGLUT1 (SLC17A7) Rev: AGGGAGGACTTGCATCTTAAGC, Ta =
60.09 °C;
SYT1 For: GCAGTGGTATGATGAAGGGCA, Ta = 52.41 °C;
SYT1 Rev: CAGTTTCCAGCCATGCATTCC, Ta = 52.38 °C;
SYT2 For: CCCTCTGCCACCATGAGAAA, Ta = 59.67 °C;
SYT2 Rev: TGTAGAGTTGTCGGCAGGTG, Ta = 59.68 °C;
SYB1 For: AGTGTTCGCTTTCATGTGGC, Ta = 59.41 °C;
SYB1 Rev: GGCCATCTTCACATCGGACA, Ta = 60.11 °C;
STX1 For: CCTTTTCCCTCCCATCCCAC, Ta = 60.03 °C;
STX1 Rev: AGATCATGCACACGACACGG, Ta = 60.74 °C;
VAMP2 For: CTGCACCTCCTCCAAACCTT, Ta = 59.89 °C;
VAMP2 Rev: CAGCTCCGACAACTTCTGGT, Ta = 59.97 °C;
GRIA1 For: AGTGGCAGTGGAGAGAATGG, Ta = 59.38 °C;
GRIA1 Rev: AGGGAATGGATTGCATGGACT, Ta = 59.43 °C;
GAPDH For: GGCATCGAAGGTGGAAGAGT, Ta = 59.75 °C;
GAPDH Rev: GGCATCTTGGGCTACACTGA, Ta = 59.75 °C;
PPIA For: TCCTGGCATCTTGTCCATGG, Ta = 59.74 °C;
PPIA Rev: TTCAGTCTTGGCAGTGCAGA, Ta = 59.53 °C;
RPL13A For: TCCGATAGTGCATCTTGGCC, Ta = 59.89 °C;
RPL13A Rev: AAGTACCAGGCAGTGACAGC, Ta = 59.96 °C.
Relative quantification of PRRT2 expression was made using the 2-
ΔΔCt method (Pfaffl, 2001), normalizing data to the geometric mean
of three housekeeping transcripts (GAPDH, PPIA, RPL13A).
2.5. Histology and immunofluorescence
Animals were anesthetized with an intraperitoneal injection of ure-
thane and transcardially perfusedwith ice-cold 4% paraformaldehyde in
0.1 M phosphate buffer (PB; pH 7.4). After perfusion, brains weredissected and kept in the same fixative solution overnight at 4 °C.
After several washes in 0.1M PB, brainswere then cryoprotected by im-
mersion in 10, 20 and 30% sucrose solutions and subsequently cut in
30 μm sections with a cryostat and stored at −20 °C in a solution con-
taining 30% ethylene glycol and 20% glycerol in 0.1 M PB. Cryosections
were thenwashed in phosphate-buffered saline (PBS, pH 7.4) and proc-
essed for free-floating immunofluorescence. After blocking step in PBS
containing 0.05% Triton X-100 and 10% normal goat serum (NGS), sec-
tionswere incubated overnight at room temperaturewith the following
primary antibodies: mouse ant-NeuN (1:500, Millipore), rabbit anti-
VGAT (1:300, Synaptic System), mouse anti-VGLUT1 (1:250, Synaptic
System). Antibodies were diluted in PBS with 3% of NGS and 0.05% Tri-
ton X-100. Double immunofluorescencewas performedwith the simul-
taneous addition of the primary antibodies. Sections were then washed
in PBS (4× 10min) and incubated for 1 h at 25 °Cwith anti-rabbit Alexa
Fluor 488 and anti-mouse Alexa Fluor 568 (Invitrogen). After several
PBS rinses, sections were mounted on glass slide and observed with a
Leica SP8 confocal microscope (Leica Microsystem). Images were ac-
quired using the multi-track mode to avoid fluorescence crosstalk (pin-
hole: 1.0 airy unit). For the quantitative analysis of VGAT and VGLUT1
puncta, Z-series stacks of seven consecutive confocal sections
(1024 × 1024 pixels) spaced by 2 μm were acquired at 40×. Images
from both channels were overlaid and background labeling was
subtracted. Fluorescence levels were analyzed on confocal images by
measuring pixel intensity using the Fiji software. Both VGAT and
VGLUT1 positive puncta were calculated using the Fiji software. Histol-
ogy was performed on the left hemisphere on neurons labeled with
anti-NeuN mouse primary antibody/anti-mouse Alexa Fluor 488 sec-
ondary antibody. Frontal, medial and caudal sections were chosen to
calculate cortex and corpus callous thickness. Medial and caudal sec-
tionswere used to analyze the thickness of both CA1 and CA3 pyramidal
cell layer and stratum radiatum. In the same section, both granule cell
layer and molecular layer thickness of the DG were analyzed. Images
from the cerebellum were always acquired from the fourth/fifth lobe
to measure the thickness of granule cell and molecular layers. Images
were acquired at 10× and all parameters were analyzed using the Fiji
software.
2.6. Behavioral analysis
Behavioral experiments were conducted during the standard light
phase, between 11.00 a.m. and 6 p.m. All mice were obtained from
HET × HET matings and three cohorts of mice were used for motor be-
havior, cognitive tests and PTZ treatment. For motor assessment, the
order of testing was as follows: (1) spontaneous behavior and righting
reflex in mouse pups; (2) open field; (3) accelerating Rotarod; and (4)
footprint test in adult mice. For the experiments in the postnatal
phase, male and female mouse pups were tested, but since no differ-
ences were detected between gender, data were collapsed across sex.
Cognitive tests and audiogenic stimulation were assessed in 2-months
old male mice and the order of testing was as follows: (1) novel object
recognition; (2) fear conditioning; and (3) audiogenic seizures. A third
cohort of 2 months old mice was used for the PTZ experiment.
2.6.1. Spontaneous movements in mouse pups
For the analysis of spontaneous movements, mouse pups were
video-recorded for 3 min at P4, P8, P12 and P16. On the day of testing,
each pup was placed into an empty standard cage located inside a
sound-attenuating styrofoambox, and assessed for spontaneous behav-
ior during a 3-min test. At the end of experimental session on the first
day of test, pups were tattooed (Ketchum permanent Tattoo Inks
green paste, Ketchum Manufacturing Inc., Brockville ON Canada) on
the paw for a subsequent recognition (Romano et al., 2013). For the
analysis of spontaneous movements, frequency and duration of behav-
ioral items were analyzed by an observer blind to mouse genotype. We
used the StatView script to manually score the following behavioral
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in the glass container), face washing (forepaws moving back and forth
from the ears to the snout and mouth), wall climbing (alternating fore-
limb placing movements on the wall of the container), pivoting (loco-
motor activity involving the front legs alone and resulting in laterally
directed movements), circling (circular locomotor activity involving
the all legs and resulting in laterally directed movements), curling
(roll, vigorous side-to-side rolling movements while on the back),
bouncing (short body jerks when the animal is placed with the four
paws on the floor), loss of balance (the animal loses control at least of
one of the four paws) and backward locomotion (the animal performs
at least backward two steps with all four paws).
2.6.2. Righting reflex in mouse pups
After each recording session, each pup was placed on its back over a
flat surface, and the time needed to return to the natural position (all
four paws on the floor) was measured. The reflex was tested once
with a cut-off latency of 60 s.
2.6.3. Somatic growth in mouse pups
At the endof the recording sessions and righting reflex test, each pup
was measured for body weight, body length, tail length and its axillary
temperature measured by gentle insertion of the thermal probe (digital
thermometer with microprobe; Stoelting Co., IL) in the skin pocket be-
tween upper foreleg and chest of the animal for about 30 s.
2.6.4. Open field test
To evaluate both locomotor activity and anxiety-like behaviors in 2-
months-old male mice, each subject underwent an open field test. Mice
were individually placed in an opaque open field box (40x40x40cm)
with the Anymaze camera (Stoelting) mounted 20 cm above the appa-
ratus. The session started by placing the animal in the center of the
arena for 10 min (habituation), followed by 20 min of test. The floor of
the apparatus was cleaned with 50% ethanol after each test. Total dis-
tance, time locomotion, time immobile, mean speed, as well as time in
the center and in the border were automatically collected using the
Anymaze activitymonitor and analyzer software system.Manual scores
using StatView software were conducted to analyze the following be-
haviors: grooming, wall rearing, jumping, loss of balance events and
backward locomotion.
2.6.5. Accelerating Rotarod
A Rotarod apparatus (Basile, Comerio, Italy) was used to measure
the mouse's balance and motor coordination at two months of age.
Each mouse was tested for three trials with the rate of rotation increas-
ing from 4 to 40 rpm during 3 min (De Filippis et al., 2010). The trial
ended when the mouse fell from the rod (3 cm diameter) or remained
on the Rotarod for at least 180 s, whichever event occurred first. The
time spent on the Rotarod was recorded by an automated unit, which
automatically stopped as the mouse fell. The mouse was placed back
in its home cage for a minimum of 10 min between each trial.
2.6.6. Footprint test
To obtain footprints, the hind- and fore- feet of themicewere coated
with red and green nontoxic paints, respectively. The animalswere then
allowed towalk along a 100-cm long, 10-cmwide runway (with 10-cm-
high walls) into an enclosed box and a sheet of millimeter paper was
placed on the floor of the runway. To characterize the walking pattern
of each mouse, the average distance between each stride (stride length,
SL), the distance between left and right hind footprints (hind-base
width, HB) and the distance between left and right fore footprints
(fore-base width, FB) were measured (Capoccia et al., 2015).
2.6.7. Novel object recognition
The novel object recognition test was conducted in the open field
arena. The test consisted of two habituation sessions (day 1 and 2), a10-min familiarization session (day 2), and a 5 min recognition test
(day 2) as previously reported (Yang et al., 2012). During the 10-min.
Familiarization session, two different objects were placed in the arena.
The objects used during the task were different in shape, color, size,
and material (glass, plastic). One hour after the familiarization session,
a 5-min novel recognition test started. One clean familiar object and
one cleannovel objectwere placed in the arena,where the two previous
objects had been located during in the familiarization phase. The famil-
iarization sessions and the recognition test were videotaped and auto-
matically scored by the Anymaze software. Object investigation was
defined as the time spent in contact with the object. Recognition mem-
ory was defined as spending significantly more time sniffing the novel
object than the familiar object. Time spent sniffing two identical objects
during the familiarization phase confirmed the lack of an innate side
bias.
2.6.8. Contextual and cue fear conditioning
The contextual and cue fear-conditioning test was conducted in
40x40x40cm arenas located inside a sound-attenuating styrofoam
box, as described (Scattoni et al., 2013). Training and conditioning
tests took place in two identical arenas calibrated to deliver identical
foot shocks. When placed in the chamber, the grid floor connected
with a circuit board for delivery of a scrambled electric shock. A camera
mounted on the front door of the environmental chamber recorded test
sessions, whichwere automatically scored using the Anymaze software.
During the training session, the mouse was placed in the test chamber
and allowed to explore freely for 2min. A pure tone (5 kHz, 80 dB) serv-
ing as the conditioning stimulus (CS)was played for 30 s. During the last
2 s of the tone, a foot shock (0.5mA)was delivered as theunconditioned
stimulus (US). Each mouse received three CS-US pairings, separated by
90 s intervals. After the last pairing, the mouse was left in the chamber
for another 2 min, during which freezing behavior was scored. Contex-
tual conditioning was tested 24 h later in the same chamber, but with-
out foot shock. Each mouse was placed in the chamber for 5 min in
the absence of CS and US, during which freezing behavior was scored.
The mouse was then returned to its home cage. Cued conditioning
was conducted 2 h after training. Contextual cues were altered by cov-
ering the grid floor with a smooth grey plastic sheet and by replacing
the black arena with a new transparent one. The session consisted of a
2 min free exploration period, followed by 1 min of the identical CS
tone (5 kHz, 80 dB) and 2moremin of free exploration. Freezing behav-
ior was scored during all segments of the test. The chamber was thor-
oughly cleaned of odors between sessions, using 50% ethanol andwater.
2.6.9. Audiogenic seizures
The test was conducted in a circular apparatus (15 cm diameter) lo-
cated inside a Startle Response/PPI test system chambers (TSE Systems
GmbH, Germany) as described (Deidda et al., 2015). The session
consisted of a 2-min free exploration period, followed by 1-min acoustic
stimulation (white noise at 120 dB) and 2moremin of free exploration.
All sessions were recorded with a digital camera (Logitech, HD Profes-
sional Webcam C920) angled 60° from above to optimize behavioral
analysis. The audiogenic responses were scored manually as: 0, no re-
sponse; 1, wild running; 2, jumping; 3, tonic-clonic seizure. The test
was conducted between 03:00 p.m. and 05:00 p.m. to avoid possible cir-
cadian variations and animals were tested only once.
2.6.10. Pentylenetetrazol-induced seizures
WT and KO littermates implanted for EEG monitoring (see below)
were repeatedly injected with unitary doses of PTZ (10mg/kg intraper-
itoneally in 0.9% saline) every 10min and continuously monitored after
each injection in a 17 × 17 × 25 cm box equipped with the Anymaze
video tracking system. Seizure scoring was conducted as previously re-
ported by Browning and Nelson (1986), and the following parameters
were considered: (i) myoclonic jerk, (ii) face and forelimb clonus (iii)
whole body clonus with twisting or loss of posture, (iv) running/
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(Browning and Nelson, 1986). At the end of the observation period, an-
imals were killed humanely by cervical dislocation. Seizure manifesta-
tions were recorded by inspection of the videos by two independent
observers blind to the genotype. Threshold dose (mg/Kg) for induction
of seizures, as well as latency (s) and duration (s) of induced seizures
were computed as previously described (McLeod et al., 2013; Rantala
et al., 2015). An integrated measure of seizure propensity was calculat-
ed, for each animal, as follows: [seizure duration]/([seizure
latency] × [threshold dose]) × 100. The total covered distance and dura-
tion of freezing events in the pre-seizure doses were automatically
assessed using the Anymaze software.
2.7. Electroencephalography
Mice tested to assess the threshold for paroxysmal events were im-
planted for wireless electroencephalogram (EEG) recordings. An EEG
transmitter [A3019D, Open Source Instruments; (Chang et al., 2011)]
was implanted subcutaneously with a subdural intracranial recording
electrode (Bregma−2.00 mm; Lateral 2.00 mm). A reference electrode
was implanted in the cerebellum (Bregma −5.80 mm; Lateral
1.00 mm). All surgeries were conducted as previously described
(Chang et al., 2011). Animals were housed separately in Faraday cages,
and EEG was recorded the day of the experiment. EEG was processed
with the Neuroarchiver tool (Open Source Instruments), which deter-
mined EEG power for different frequency bands. The trace was centered
around 0V by subtraction of the average. Short (b100 ms), high-ampli-
tude artifacts exceeding 5× root mean square (‘glitches’) detected by
threshold and periods with failed transmission were high pass–filtered
at 10 Hz.
2.8. Patch-clamp recordings in hippocampal and cerebellar slices
Acute hippocampal and cerebellar slices were prepared from 4 to 8
weeks-old WT and PPRT2 KO littermates with the genotype blind to
the experimenter. Mice were anesthetized by a brief exposure to
isoflurane, decapitated and the brain rapidly dissected in an ice-cold
cutting media containing (in mM): 87 NaCl, 25 NaHCO3, 2.5 KCl, 0.5
CaCl2, 7 MgCl2, 25 glucose, 75 sucrose and saturated with 95% O2 −
5% CO2. Coronal and sagittal slices (350 μm) were obtained from the
hippocampus and cerebellum, respectively, with a Microm HM 650 V
microtome equipped with a Microm CU 65 cooling unit (Thermo Fisher
Scientific, Waltham, MA) to maintain the cutting-media at low temper-
ature (2–5 °C) while slicing. Before starting the recordings, slices were
allowed to recover for 30–45 min at 35 °C in a constantly 95% O2 − 5%
CO2 bubbled recording artificial cerebrospinal fluid (ACSF) solution con-
taining (in mM): 125 NaCl, 25 NaHCO3, 25 glucose, 2.5 KCl, 1.25
NaH2PO4, 2 CaCl2 and 1 MgCl2. Following recovery, slices were kept at
room temperature for the rest of the experimental day. For all experi-
ments on glutamatergic transmission, a high K-gluconate intracellular
solution was used (containing in mM: 126 K-gluconate, 4 NaCl, 1
MgSO4, 0.02 CaCl2, 0.1 BAPTA, 15 glucose, 5 HEPES, 3 MgATP, and 0.1
NaGTP, pH 7.3, 290 mosmol/l), while a high-chloride intracellular solu-
tion (containing inmM: 126KCl, 4 NaCl, 1MgSO4, 0.02 CaCl2, 0.1 BAPTA,
15 glucose, 5 HEPES, 3 MgATP and 0.1 NaGTP, pH 7.3, 290 mosmol/l)
was used for the investigation of GABAergic transmission. QX314
(10 mM) was also added to the intracellular solution for ePSC record-
ings. Patch-clamp experiments were performed with borosilicate pi-
pettes, pulled with a Narishige PC-10 vertical puller to a final
resistance of 3–4mΩ, using theMulticlamp700B or AxoPatch 200B am-
plifier (Molecular Devices, Sunnyvale, CA). Data were acquired with a
2 kHz low-pass Bessel filter and digitized at 10 kHz with Clampex 10.2
and analyzed offline with Clampfit 10.2 (pClamp, Molecular Devices,
Sunnyvale, CA), MiniAnalysis (Synaptosoft, Decatur, GA) and Origin
(OriginLab,MA). Extracellular stimulation to evoke PSCswas performed
with a monopolar glass electrode (intensity: 10–100 mA, duration: 5–10 μs) filled with ACSF and connected with an isolated pulse stimulator
(A-M Systems, Carlsborg, WA). The criteria used to define the extracel-
lular stimulation were: (1) no failures in response to repeated 0.1 Hz
stimulation; (2) postsynaptic responses at least three-fold higher than
the square root of noise; (3) latency and shape of synaptic current
remained invariant. After finding a cell that met these criteria, we con-
tinued all the experiments at stimulation intensity 10% higher than
the minimal needed, to avoid possible failures.
2.8.1. Hippocampus
Whole-cell recordings were performed on visually identified den-
tate gyrus (DG) granule cells (GCs) as previously described (Medrihan
et al., 2013). We recorded mature GCs with Rm b 300 MΩ at a holding
potential of −70 mV in which PSCs were evoked by stimulation of the
medial perforant path. Evoked excitatory postsynaptic current (eEPSC)
recordings were recorded in the presence of SR95531 (10 μM), CGP
55845 (5 μM) and D-AP5 (50 μM),while evoked inhibitory postsynaptic
current (eIPSC) recordings were performed in the presence of D-APV
(50 μM), NBQX (20 μM) and CGP 55845 (5 μM) (all from Tocris Biosci-
ence, Ellisville, MO). For recordings of miniature EPSCs/IPSCs, 0.3 μM
TTX was added to the recording solution.
2.8.2. Cerebellum
Whole-cell recordings were obtained from Purkinje cells (PCs) that
were voltage-clamped at −60 mV with 60–80% RS compensation, as
previously described (Valera et al., 2012) with some modifications.
eEPSCs were elicited by parallel fibers electrical stimulation via a glass
stimulation pipette placed in the molecular layer N 100 μm away from
the recorded cell to avoid the direct stimulation of the dendritic tree.
To avoid plasticity, trains of parallel fibers stimulation were applied in
the presence of the CB1 receptor antagonist AM251 (1 μM), the specific
mGluR1 receptor antagonist JNJ16259685 (1 μM), the pre-/post-synap-
tic GABAB receptor antagonist CGP55845 (3 μM). D-APV (100 μM) and
SR95531 (10 μM) were also added to the recording solution. mEPSCs
were recorded in presence of SR95531 (5 μM), CGP55845 (3 μM) and
TTX (0.3 μM).
2.9. Statistical analysis
Data are expressed asmeans ± SEM for number of cells throughout.
Normal distribution of data was assessed using the D'Agostino-
Pearson's normality test. The F-test was used to compare variance be-
tween two sample groups. To compare twonormally distributed sample
groups, the two-tailed unpaired Student's t-test was used. To compare
more than two normally distributed sample groups, one- or two-way
ANOVA was used, followed by the Bonferroni's, Dunnett's or Fisher
PLSD test. The occurrence of a given behavioral trait in the mouse pop-
ulationwas evaluated using the Fisher exact test. A value of p b 0.05was
considered significant. Statistical analysis was carried out using
OriginPro-8 (OriginLab Corp., Northampton, MA, USA), StatView 5.01
(SAS Institute, Inc.) and Prism (GraphPad Software, Inc.) software.
3. Results
3.1. Characterization of PRRT2 KO mice
After the demonstration that successful homologous recombination
had occurred in our PRRT2 mice by PCR (Fig. S1B), we confirmed the
creation of a null allele for PRRT2 by analyzing the expression of
PRRT2 protein in various brain areas in adult WT, HET and KO mice by
quantitative immunoblotting (Fig. S1C). In agreementwith the previous
report (Valente et al., 2016), PRRT2proteinwas highly expressed in sev-
eral areas of theWTbrain, including cerebellum, frontal, sensory and vi-
sual cortices, hippocampus, striatum and brain stem. In KO mice, the
immunoreactive 68 kDa PRRT2 band was totally undetectable by west-
ern blotting in fractions from any of the brain regions analyzed, while
Fig. 1. Somatic growth during postnatal development. A. Representative picture of WT, HET and KO PRRT2 mouse pups at P4 and P16. B–E. Analysis of the markers of somatic growth
revealed no differences between WT, HET and KO mice during development on body weight (B), body temperature (C), body length (D) and tail length (E). Data (means ± SEM)
were obtained from cohort 1 (10 litters): N = 15WT, 43 HET and 17 PRRT2 KO. Two-way ANOVA and post-hoc Fisher PLSD test.
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(Fig. S1C).
Offspring of HET mice, genotyped by PCR, were found to follow the
expected Mendelian distribution and no prenatal lethality was ob-
served. The somatic growth and general health status in KO animals
were indistinguishable from those observed in both HET andWT litter-
mates, with normal somatic growth in terms of bodyweight, body tem-
perature, body length and tail length over postnatal development
(Fig. 1A–E).
Although thebrain gross structure appeared comparable in the three
genotypes, we performed a morphometric analysis at various rostro-
caudal levels based on NeuN immunoreactivity. Intriguingly, the thick-
ness of the neocortex in young adult PRRT2 KO mice was significantly
reduced in medial and caudal regions compared to their WT controls,
in the absence of changes in cortical thickness in frontal regions and in
the thickness of the corpus callosum at all levels analyzed (Fig. 2A–C).
Moreover, no significant differences were observed in the thickness of
the CA1, CA3 and DG regions of the hippocampus, as well as for themo-
lecular and granule layers of the cerebellum (Fig. S2).
3.2. Regional expression of PRRT2
We used β-gal activity to follow the precise regional and cellular ex-
pression pattern of PRRT2 in the mutant mice. We analyzed the rostro-
caudal expression pattern of β-gal in coronal sections from the brain
and spinal cord of HET and KO mice at various postnatal times and in
young adults (Fig. 3).
On a macroscopic level, β-gal appeared strongly expressed in the
cerebellum and hindbrain with respect to more rostral areas (Fig. 3A).
Examination of the entire nervous system frommutant mice confirmed
an average low expression level of β-gal in the forebrain, but with hot
spots of expression in restricted areas. The analysis of rostral sections re-
vealed high expression levels in layer VIb of the neocortex, septal nuclei
and claustrum (Fig. 3B). Atmore caudal levels, the β-gal signal was high
in the hippocampus, particularly in the hilus, DG and CA3, with lowerβ-
gal activity in the CA1, CA2 areas (Fig. 3C, D). Specific signals were also
observed in the amygdala, collicula and periaqueductal grey (Fig. 3D). In
more caudal sections, a strong expression of PRRT2 was detected in the
granular layer of cerebellum,whereas PCs and themolecular layer were
negative except for sparse positive interneurons in the latter. A faint
staining was also detected in the medulla oblongata at the level of thevestibular nuclei (Fig. 3E). Finally, PRRT2 expression was observed in
the spinal cord, with intense β-gal staining in the substantia gelatinosa
as well in the dorsal horn (Fig. 3F). No β-gal staining was present in
the white matter, confirming the neuron-specificity of PRRT2 expres-
sion. PRRT2 expression was very low at postnatal day (P) 4 and 8,
while at P16 its expressionmarkedly increased,with a regional distribu-
tion similar to the adult (not shown). This finding agrees with our pre-
vious study inwhichwe found that PRRT2mRNA, low at birth, increases
postnatally over the first month of life (Valente et al., 2016).
To assess the specificity of the PRRT2-promoter driven expression of
β-gal, we compared the mRNA levels of PRRT2 and β-gal in three major
areas of WT, HET and KO brains, namely frontal cortex, hippocampus
and cerebellum, characterized by significantly different β-gal activities
(Fig. 3G). This analysis confirmed that in WT brains the cerebellum
has much higher levels of PRRT2 transcript than cortical areas, and
that the expression levels are reduced to approximately 50% in HET
brains and virtually absent in KO brains. Accordingly, the parallel quan-
tification of the LacZ transcript in the three genotypes revealed progres-
sively increasing expression levels in HET and KO brains, with a
cerebellum/cortical expression ratio similar to that observed for PRRT2
mRNA in HET and WT brains, respectively (Fig. 3G). The comparison
of the expression of PRRT2 protein in various brain areas (Fig. S1C)
with the mapping of β-gal/PRRT2 transcript reveals the existence of
mismatches, particularly at the level of the cortex and the striatum
that exhibit low levels of cellular transcript, but high expression of
PRRT2 protein.
3.3. Behavioral phenotyping of the PRRT2 mouse line
3.3.1. Spontaneous motor behavior and righting reflex in PRRT2 mouse
pups
In this test a significant genotype effect was observed in bouncing
behavior (F2,210 = 4.684, p = 0.01; Fig. 4A) and an interaction
genotype × day in the loss of balance (F6,210 = 2.265, p = 0.03; Fig.
4B), backward locomotion (F6,210 = 5.432, p = 0.0001; Fig. 4C) and
grooming (F6,210 = 2.792; p = 0.01, Fig. 4D), while no differences
were found in the other parameters analyzed (Fig. 4E). Interestingly,
post-hoc tests revealed a higher frequency of abnormal events in KO
micewhen compared toHET andWT starting fromP8, a crucialwindow
formotor development, since at this time point animals start moving all
four paws on thefloor (see circling and locomotion in Fig. 4E). PRRT2 KO
Fig. 2.Gross brain histology of cerebral cortex and corpus callosum. Representative confocal images of NeuN staining (green) in themotor (A), somatosensory (B) and visual (C) cortices of
WT and PRRT2 KOmice and the respectivemorphometric analysis of the thickness of both cortex and corpus callosum. Data are expressed as means± SEM; **p b 0.01, ***p b 0.001; two-
tailed unpaired Student's t-test. N = 3 for both WT and KO mice. Scale bar, 100 μm.
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Fig. 3. β-gal activity in the CNS of adult PRRT2 KOmice. A. Representative picture of β-gal staining in isolated adult brains fromWT, HET and KO PRRT2mice. A strong expression of β-gal
was evident in the cerebellum of HET and KOmice, while WTmice were negative. B. PRRT2 was expressed in layer VIb of the neocortex (B1), septal nuclei (B2) and claustrum (B3). C, D.
PRRT2was expressed in hippocampal regions, particularly DG, hilus and CA3 (C1, D1, D2). Thalamic regions, amygdala (C2), periaqueductal grey, superior colliculus and neocortical layer
VIbwere also positive. E. A strong expression of PRRT2was present in the cerebellum, particularly in the granular cell layer, while Purkinje cells were negative (E1). In themolecular layer,
only sparse interneuronswere positive (E2). F. An intense PRRT2 expressionwas present in the substantia gelatinosa and the dorsal horn of the spinal cord (F1-F2). Scale bars: 2mm (B-D),
1 mm (E, F) and 0.1 mm (insets). N= 3 PRRT2 KOmice. G. Quantitative analysis of PRRT2 (left) and LacZ (right) mRNA levels (means± SEM) in the cortex (CX), hippocampus (HIP) and
cerebellum (CB) ofWT, HET and KOmice by qRT-PCR. *p b 0.05, ***p b 0.001, one-way ANOVA and post-hoc Bonferroni's test. Samples were run in triplicate from N= 3 for bothWT and
KO mice.
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Fig. 4.Motor behavioral patterns shown by PRRT2mouse line during postnatal development and at adulthood. A–D. A higher frequency of bouncing (A), loss of balance (B), backwalking
(C) and a longer duration of grooming (D) were observed in KOmouse pups as compared with HET andWT littermates during 3-min maternal separation at P4, P8, P12 and P16. E. The
panel represents thepercentage of time spent byWT, HET andKOpupsperforming the various behaviors analyzed at P4, P8, P12 and P16. F. Righting reflex latenciesmeasured at the end of
thematernal separation test. N=14WT, 43HET and 17KOmouse pups. G–H. A higher frequency of loss of balance (G) and backwalking (H)was still present in adult PRRT2 KOmice. N=
8 WT, 14 HET and 13 KO male mice. All data are expressed as means ± SEM; *p b 0.05, **p b 0.01, ***p b 0.001; two-way ANOVA and post-hoc Fisher PLSD test.
74 C. Michetti et al. / Neurobiology of Disease 99 (2017) 66–83mice experienced loss of balance with high frequency at P8 and started
to display backward locomotion (moonwalking) at P12. The most criti-
cal picture was seen at P16, when a mature motor profile was reached
by all three genotypes with locomotion and wall climbing behaviors
(see Fig. 4E). At this time point, post-hoc tests confirmed a higher fre-
quency of balance loss, backward locomotion and grooming duration
in KO mice when compared to either WT or HET mice. Interestingly, at
P12 and P16, the presence of bouncing persisted in HET and KO mice,
but not inWT littermates. Given themotor abnormalities observed dur-
ing spontaneous behavior, we investigated the righting reflex that re-
quires a complex coordination between head, trunk, and paws (Fig.
4F). We limited the analysis to the developmental milestones of the
righting reflex, to avoid stressful manipulations that could potentiallytrigger motor paroxysms. No genotype differences were found in the
righting reflex latency, suggesting a normal motor coordination devel-
opment in PRRT2 mouse line (Fig. 4F). Altogether, our screening in
PRRT2 KO mouse pups uncovered the presence of paroxysms, namely
bouncing and back walking, together with uncontrolled grooming, in
spite of the presence of a physiological pattern of motor development.
3.3.2. Spontaneous and evoked motor behavior in PRRT2 adult mice
At adulthood, we found a genotype effect for loss of balance (geno-
type effect F2,32 = 3.903, p = 0.03; Fig. 4G) and backward locomotion
(genotype effect F2,32=4.658, p=0.01; Fig. 4H;Movie S1), with nodif-
ferences in grooming and locomotion (Fig. S3A–C). No significant geno-
type-specific differenceswere also observedwhen the time spent by the
Fig. 5. Paroxysmal phenotype of PRRT2 KOmice. A.Motor paroxysms in response to audiogenic stimuli. A1. Representative trackings ofWT, HET and KOmice during 1-min exposure to an
audiogenic stimulus (white noise, 120 days; A1). A2. EEG recorded inWT and PRRT2 KOmice during the resting adaptation period. A3. Representative EEG traces of PRRT2 KOmice during
the audiogenic response before and during wild running. A4–A7. The plots show the percentage of animals responding with wild running to the audiogenic stimulus (A4), the mean
duration of wild running (A5), the percentage of animals performing jumps (A6) and the frequency of back walking performed during the audiogenic response (A7) as means ± SEM.
N = 6 WT, 7 HET and 6 KO male mice. B. Pentylenetetrazol-induced seizures. A 10-s representative EEG trace of a PRRT2 KO mouse recorded during a PTZ-induced tonic-clonic seizure
is shown (B1). The plots (means ± SEM) depict: the total distance covered (B2) and the duration of the immobility/freezing episodes (B3) collectively recorded at subthreshold PTZ
doses (10, 20 and 30 mg/kg); the threshold for provocation of the first tonic-clonic seizure (B4); the seizure latency from the administration of the threshold doses (B5); the duration
of the first tonic-clonic seizure (B6); and the compound seizure propensity index (B7) calculated as described in the Materials and Methods. Statistical analysis was performed using
the Fisher exact test (A4, A6) and two-way ANOVA and post-hoc Fisher PLSD test (A5, A7, B2–B7). **p b 0.01; ***p b 0.001. N = 6 WT, 7 HET and 6 KO (A); 7 WT and 6 KO (B).
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Fig. 6. Expression of synapticmarkers in PRRT2 KOmice. Representative confocal images of the hilus of theDG (A) and of the granule cell (upper panel) andmolecular (lower panel) layers
of the cerebellum (B) of WT and PRRT2-KO mice stained with DAPI (blue), VGAT (green), VGLUT1 (red) and their merge. Histograms on the right show the mean intensity VGAT and
VGLUT1 immunoreactivities and the number of VGAT- and VGLUT1-positive puncta. (ML: molecular layer; GL: granule cell layer; H: Hilus; PL: Purkinje cell layer). All data are
expressed as means ± SEM; *p b 0.05, **p b 0.01; two-tailed unpaired Student's t-test. N = 3 for both WT and KO. Scale bar, 150 μm.























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































77C. Michetti et al. / Neurobiology of Disease 99 (2017) 66–83animals in the center versus the perimeter of the open field and the fre-
quency of line crossing in these areas were analyzed, suggesting a nor-
mal anxiety level in the PRRT2 KO mouse line (Fig. S3D–E). Given the
presence of balance problems and backward locomotion in the PRRT2
mouse line, we challenged the motor adaptation/coordination by
means of the accelerating Rotarod and foot print tests. In both tests no
significant differences between genotypes were found (Fig. S4). Overall
our results in the adult PRRT2 KOmice are consistent with the data col-
lected in mouse pups and indicate that the occurrence of paroxysmal
events is the main phenotypic trait, in the presence of a normal
motor/coordination profile.
3.3.3. Cognitive behavior in PRRT2 adult mice
Since patients bearing homozygous mutations in PRRT2 show a se-
vere encephalopathy associated with intellectual disability, we under-
took the study of cognitive behavior in the PRRT2 mouse line using
the novel object and cued/contextual fear conditioning tests. Both
tests revealed the absence of genotype-specific differences between
WT, HET and KO mice. (Figs. S5 and S6). These data suggest that, at
least for short-lasting memory, PRRT2 HET and KOmice are not signifi-
cantly impaired and their performances are indistinguishable fromWT
littermates.
3.4. Paroxysmal phenotypes of PRRT2 KO mice
Adult PRRT2 KOmice, studied by video-EEG under basal conditions,
did not display spontaneous motor seizures or any significant paroxys-
mal alteration of the major EEG rhythms. However, when PRRT2 KO
mice were challenged with a single 60-s 120 dB white tone or with in-
creasing doses of PTZ, they exhibited a strong propensity for the expres-
sion of paroxysmal motor behaviors (Fig. 5A).
Virtually 100% of the PRRT2 KO mice presented sound-induced au-
diogenic seizures (AGS), consisting in a wild, explosive and uncon-
trolled running episodes that manifested with an average latency of
25.2 ± 7.2 s and an average duration of 18.5 ± 5.4 s. Wild running
was mostly unidirectional and was intermingled by back walking epi-
sodes that were accompanied by jumping in 50% of the cases (Fig. 5A;
Movies S2, S3). However, wild running was never followed by the de-
velopment of myoclonies or overt tonic-clonic seizures andwas charac-
terized by an unaltered cortical EEG (Fig. 5A). Sharply, none of the WT
littermates responded to the same sound stimulus with any locomotor
activation or epileptic seizure.
The hyperexcitability of brain networks of PRRT2 KO mice was also
assessed by the administration of increasing doses of the convulsant
PTZ. No significant differences were noticed in the distance travelled
or in the duration of the rigidity/freezing episodes at sub-threshold
PTZ concentrations, as well as in the threshold for seizures (WT:
57.14 ± 4.21; KO: 58.33 ± 4.77 mg/kg) and in the latency for seizures
(WT: 393.2 ± 71.3; KO: 304.3 ± 79.1 s). However, a highly significant
longer duration of seizures was observed in PRRT2 KO mice as com-
pared to WT littermates (WT: 28.0 ± 3.3; KO: 151.0 ± 40.7 s; Fig. 5B).
When a compound parameter indicating the overall seizure propensity,
and including threshold, latency and duration of seizures, was comput-
ed (see Materials and Methods), PRRT2 KOmice displayed significantly
higher values than their WT companions (WT: 0.20 ± 0.03; KO: 1.20 ±
0.3; Fig. 5B).
3.5. Synaptic connectivity in PRRT2 KO mice
Given that the electrical activity in paroxysmal manifestations is
often associated with excitation/inhibition imbalance and/or network
instability, we analyzed the number of excitatory and inhibitory synap-
ses (identified as VGLUT1- and VGAT-positive puncta, respectively) in
the molecular layer and hilus of DG and in the granular and molecular
layers of the cerebellum, two areas where the β-gal staining was most
intense.
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79C. Michetti et al. / Neurobiology of Disease 99 (2017) 66–83Analysis of the hilus of DG of PRRT2 KO slices (Fig. 6A) revealed an
increase in both VGLUT1 mean intensity (WT: 17.62 ± 0.10; KO:
23.97 ± 1.49; p b 0.05) and number of puncta (WT: 1024 ± 95; KO:
2104 ± 106; p b 0.01), in the absence of significant differences in
VGAT mean intensity or number of puncta. No genotype-dependent
changes were observed in the mean intensity and number of puncta
of both VGLUT1 and VGAT in the molecular layer of the DG (Fig. S7).
In the granule cell (GC) layer of the cerebellum (Fig. 6B, upper
panels), VGAT mean intensity and number of puncta were unchanged,
while the VGLUT1 mean intensity, but not the number of puncta, was
significantly decreased in PRRT2 KO slices (WT: 11.77 ± 1.37; KO:
4.22 ± 1.14; p b 0.05). On the other hand, in the molecular layer of
the cerebellum (Fig. 6B, lower panels), an increase in VGATmean inten-
sity (WT: 22.43 ± 2.83; KO: 54.147 ± 7.859; p b 0.05), but not in the
number of puncta was observed in PRRT2 KO slices, in the absence of
any change in VGLUT1 mean intensity and positive puncta.
We also analyzed the expression levels of synaptic proteins in brain
samples from WT, HET and KO mice using qRT-PCR. The analysis was
extended to specific synaptic markers, such as synaptophysin1 (SYP1),
VGLUT1 and VGAT, as well as to proteins that were previously shown
to interact with PRRT2 such as SNAP25, syntaxin1 (STX1), VAMP/
synaptobrevin2 (VAMP2), synaptotagmins 1/2 (SYT1/2) and the
GRIA1 subunit of AMPA receptors (Lee et al., 2012; Li et al., 2015;
Valente et al., 2016). Quantitative analysis of themRNA levels in the cor-
tex, hippocampus and cerebellum (Table 1) revealed area- and geno-
type-specific changes in several of the analyzed transcripts. In
particular, significant decreases in the mRNAs of SNAP25 and SYT1/2
were observed in the cortex, of SNAP25, VAMP2 and SYP1 in the hippo-
campus and of SNAP25 and SYT2 in the cerebellum. Notably, most of the
transcriptional changes regarded presynaptic PRRT2 interactors, while
the expression of its postsynaptic interactor GRIA1 was not affected in
any of the three brain areas. In addition, in the cerebellum, a significant
decrease in VGLUT1 transcript was observed, consistent with the de-
creased immunoreactive levels observed with immunohistochemistry.
3.6. Electrophysiology of PRRT2 KO hippocampal and cerebellar slices
To investigate the synaptic effects of PRRT2 deletion in the DG, we
made whole-cell voltage-clamp recordings of the DG GCs in hippocam-
pal slices of 4-weeks old PRRT2 KO mice and age-matched WT litter-
mates. We first recorded miniature EPSCs (mEPSCs) from granule
neurons in the presence of 0.3 μM tetrodotoxin (TTX). We noticed an
over two-fold increase in the frequency ofmEPSCs in PRRT2 KOneurons
(Fig. 7A), in the absence of any effect on amplitude. We then employed
extracellular stimulation of the medial perforant path with paired stim-
uli to elicit monosynaptic excitatory and inhibitory responses in GCs. No
changes between genotypes were observed in the eEPSC amplitude and
in the paired pulse ratio at inter-pulse intervals ranging from 10 ms to
4 s (Fig. 7B).When inhibitory transmission was analyzed, no significant
changes in either frequency or amplitude of miniature IPSCs (mIPSCs)
were noticed (Fig. 7C). However, when evoked inhibitorymonosynaptic
responses were analyzed, the amplitude of eIPSCs was significantly in-
creased in PRRT2 KO neuronswith a corresponding significant decrease
in the PPR at short inter-pulse intervals (ISI: 10–25ms) (Fig. 7D). No sig-
nificant changes in the dynamics of depression during high frequency
trains (2 s @ 40Hz)were observed in PRRT2KOmice for both excitatory
and inhibitory transmission (Fig. S8).Fig. 7. Electrophysiology of PRRT2 KO hippocampal slices. A. Representative mEPSC traces reco
amplitude and frequency of mEPSCs are reported on the right for WT (open bars) and PRRT
neurons from WT (3 mice) and PRRT2 KO (3 mice), respectively. B. Left: Representative traces
or paired (bottom) stimuli. Right: Mean (±SEM) eEPSC amplitude (top) and paired-pulse rati
bar/symbol) and PRRT2 KO (black bar/symbol) mice. N = 14 and 13 neurons from WT (4 mi
fromWT and PRRT2 KO mice in the presence of TTX. The mean (±SEM) amplitude and frequ
mice. N = 20 and 17 neurons from WT (3 mice) and PRRT2 KO (3 mice), respectively. D. Lef
response to single (top) or paired (bottom) stimuli. Right:Mean (±SEM) eIPSC amplitude (to
bar/symbol) and PRRT2 KO (black bar/symbol) mice. *p b 0.05, two-tailed unpaired Student'sGiven the high PRRT2 expression in cerebellar granule cells, and the
motor phenotype of PRRT2 KOmice, we next concentrated on the anal-
ysis of the PF-PC synapse. Purkinje cells in sagittal cerebellar slices ob-
tained from juvenile (4-weeks old) WT and PRRT2 KO littermates
were patched in the presence of a complete blockade of NMDA,
GABAA, pre- and post-synaptic GABAB, CB1 and mGLU1 receptors to
limit modulation of EPSC amplitude by stimulation-dependent activa-
tion of these receptors. No significant changes were observed in the fre-
quency and amplitude of mEPSCs recorded in the presence of TTX (Fig.
8A). The absence of postsynaptic effects and the unchanged frequency
of mEPSCs are consistent with the absence of PRRT2 expression in PCs
and with a normal density of VGLUT1 puncta labeling the PF terminals
in the molecular layer (Figs. 3E and 6B). When postsynaptic responses
were evoked by minimal extracellular stimulation of parallel fibers in
the molecular layer with single and paired stimuli at increasing ISIs
(from 10ms to 4 s), no changes were observed in both eEPSC amplitude
and PPR at any of the intervals tested (Fig. 8B). Next, we subjected the
PF/PC synapse to high frequency stimulation trains at various frequen-
cies from 10 to 40 Hz lasting 2 s (Fig. 8C) to assess the presynaptic dy-
namics of short-term plasticity and the rate of replenishment of the
release sites in the presence or absence of PRRT2. Under the experimen-
tal conditions used, synaptic responses in WT slices exhibited an early
facilitation phase followed by a depression phase, the amplitude of
which were both proportional to the stimulation frequency. Strikingly,
in PRRT2 KO synapses facilitation was long lasting and depression was
not present even at the highest stimulations frequency. The effect was
particularly evident when cumulative plots of EPSC amplitude, normal-
ized by the first response in the train, were extracted from the data. In
PRRT2 KO synapses, significantly higher slopes were present at all test-
ed frequencies, indicating an accelerated replenishment of the readily
releasable pool.
4. Discussion
As PRRT2 mutations are predominantly loss-of-function, the PRRT2
KO mouse described here represents an important experimental
model to reproduce the conditions of PRRT2 deficiency present in the
patients.
4.1. PRRT2 has a very specific regional expression in the central nervous
system
PRRT2 has a strictly area-specific expression, as deduced from β-gal
expression driven by the PRRT2 promoter. β-gal was expressed in char-
acteristic regions of the central nervous system (CNS), but was not
widespread. Interestingly, the expression was particularly high in neu-
rons of the lower hindbrain, cerebellum and spinal cord, reminiscent
of the expression pattern of its major interactor Syt2 (Pang et al.,
2006; Valente et al., 2016). While a substantial agreement exists with
the levels of the PRRT2 protein for cerebellum and hippocampus, a dis-
crepancy was observed in the basal ganglia and neocortex that exhibit
low mRNA levels and high levels of the PRRT2 protein. Taking into ac-
count the predominant presynaptic expression of PRRT2, this means
that neocortex and basal ganglia are targets of projections coming
from other areas rich in PRRT2-expressing neurons.
Some specific sites of high PRRT2mRNA expression are noteworthy.
Areas of very high expression include the claustrum, some thalamicrded in DG GCs fromWT and PRRT2 KO mice in the presence of TTX. The mean (±SEM)
2 KO (black bars) mice. *p b 0.05, two-tailed unpaired Student's t-test. N = 18 and 12
of eEPSCs from WT (black traces) and KO (red traces) DG GCs in response to single (top)
o (PPR) plotted as a function of the inter-stimulus interval (ISI: 10 ms-4 s) for WT (open
ce) and PRRT2 KO (4 mice), respectively. C. Representative mIPSC traces recorded in GCs
ency of mIPSCs are reported on the right for WT (open bars) and PRRT2 KO (black bars)
t: Representative traces of eIPSCs from WT (black traces) and KO (red traces) DG GCs in
p) and paired-pulse ratio (PPR) plotted as a function of the ISI (10 ms-4 s) for WT (open
t-test. N = 13 and 12 neurons from WT (4 mice) and PRRT2 KO (4 mice), respectively.
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involved in processing sensory information. The intense staining of the
dorsal horn of the spinal cord, and in particular of the substantia gelati-
nosa, in which physiological processing of somatosensory and nocicep-
tive stimuli takes place (Zeilhofer et al., 2012), also implicates PRRT2 in
the relay between sensory information and motor output.
The only strongly labeled neocortical layer VIb projects specifically
to the claustrum (Goll et al., 2015). On the other hand, the claustro-cor-
tical connectivity is mediated by strong glutamatergic projections to
many cortical layers, primarily layer IV, but also layers I/II and VI. The
abundant glutamatergic claustro-cortical connections, together with
the presynaptic targeting of the PRRT2 protein can account for the
high PRRT2 immunoreactivity present in the cortex. The high PRRT2 ex-
pression occurring in claustrum and layer VIb of the cortex suggests an
involvement of PRRT2 in the cortical/claustral/cortical circuit that plays
an important role in multi-sensory integration and sensorimotor coor-
dination and can be potentially involved in the pathogenesis of senso-
ry-triggered paroxysmal events (Goll et al., 2015; Italiano et al., 2016).
In the hippocampus, positivity is concentrated in the hilus of DG,
where mossy cells are present and control the excitability of DG GCs.
Glutamatergic mossy cells have a mild excitatory effect on GCs, but
that also activate DG interneurons that potently inhibit GCs. Because
of this feed-forward inhibition, mossy cells are believed to prevent sei-
zures and their impairment has been often associated with epilepsy of
hippocampal origin (Scharfman, 2016; Toader et al., 2013).
4.2. PRRT2 KO mice do not have overt abnormalities in brain development
PRRT2 inactivation did not affect the viability of the KO embryos or
their survival after birth. The absence of peripheral pathologies is con-
sistent with the neuron-specific expression of PRRT2 (Chen et al.,
2011; Lee et al., 2012; Valente et al., 2016), while the absence of an
overt neurological phenotype indicates that PRRT2 is dispensable for
basal CNS functions.
Paroxysmal disorders, such as partial epilepsies, often result from
brain lesions or dysplasia. Despite no major abnormalities were ob-
served in the brain morphology of PRRT2 KO mice, a detailed analysis
of the architecture of the neocortex, hippocampus and cerebellum re-
vealed a consistently decreased neocortical thickness in sensory areas
(e.g. the somatosensory and visual cortices), with no detectable changes
in hippocampus, cerebellum or white matter cytoarchitecture. This
finding is consistentwith the delayedmigration of cortical neurons dur-
ing development and the decreased synaptic density observed in vitro
and in vivo upon downregulation of PRRT2 expression (Liu et al.,
2016; Valente et al., 2016).
4.3. PRRT2 KO mice display motor paroxysms
Both pups and adult KOmice were not affected by spontaneous sei-
zures and their intercritical EEG did not exhibit any abnormalities, indi-
cating a normal basal rhythmogenesis. However, they displayed a sharp
paroxysmal phenotype, including gait problems and paroxysmal back
walking, that recapitulates the most common clinical manifestations
of the human PRRT2-linked diseases. These episodes were present
from the early stages of life and were also detectable in the adult, rem-
iniscent of the early temporal window of the pathologic manifestationsFig. 8. Electrophysiology of PRRT2 KO cerebellar slices. A. RepresentativemEPSC traces recorded
and frequency of mEPSCs are reported on the right forWT (open bars) and PRRT2 KO (black ba
Left: Representative traces of eEPSCs fromWT (black traces) and KO (red traces) mice in respon
and paired-pulse ratio (PPR) plotted as a function of the inter-stimulus interval (ISI: 10 ms-4 s)
enhances synaptic facilitation during high frequency trains. Left:Mean (±SEM) normalized val
PCs subjected to 2 s high-frequency stimulation at 10 (top), 20 (middle) and 40 (bottom) H
stimulation. Right: Cumulative plots of normalized EPSC amplitudes during trains at 10 (top), 2
Individual slopes were calculated from the last 10 responses in the train and statistically co
0.021 ± 0.003, p b 0.05; 40 Hz: 0.017 ± 0.004 and 0.054 ± 0.010, p b 0.05; for WT and PRR
N = 11 and 18 neurons fromWT (3 mice) and PRRT2 KO (3 mice), respectively.in patients (Ebrahimi-Fakhari et al., 2015). These disturbances are rem-
iniscent of episodic ataxia found in patients bearing PRRT2 mutations
and strongly implicate the cerebellum, a brain region with very high
PRRT2 expression, in their pathogenesis.
PRRT2 KO mice were highly prone to audiogenic paroxysms with
wild running, back walking and jumping and displayed a higher pro-
pensity for generalized PTZ-evoked seizures. In both kinds of provoca-
tions, however, the seizure propensity was not very severe, consistent
with themild epileptic phenotype of patients bearing PRRT2mutations
(Ebrahimi-Fakhari et al., 2015; Gardiner et al., 2015;Heron andDibbens,
2013). In fact, AGS never progressed beyond thewild running stage and
the convulsive threshold for PTZ in PRRT2 KO mice was similar to WT
animals, although tonic seizures weremore severe. The epileptic nature
ofwild running in response to audiogenic stimuli has been supported by
its potential progression to generalized seizures (Simler and Vergnes,
1999; Vinogradova, 2015). It is known that high sensitivity to AGS in-
volves neuronal networks located primarily in the brainstem, including
the inferior and superior collicula and the periaqueductal grey
(Chakravarty and Faingold, 1999; Faingold, 1999; N'Gouemo and
Faingold, 1999). The amygdala complex is also involved in the genera-
tion of AGS, although its role becomes primary in AGS kindling
(Chakravarty and Faingold, 1999). Notably, high expression levels of
β-gal/PRRT2 are present in the collicola, periaqueductal grey and amyg-
dala. However, the lack of progression to tonic-clonic seizures, the pre-
served EEGgraphic activity and consciousness, together with the
presence of back walking make these episodes resemble paroxysmal
compulsivemotormanifestations of complex nature, in which dysfunc-
tions of multiple brain circuits, including the cerebellum, may be
involved.
The vast majority of patients carry PRRT2mutations in heterozygos-
ity (Heron and Dibbens, 2013). However, heterozygousmice do not dis-
play any pathogenic phenotype, except for the persistence of bouncing
during postnatal development. In contrast, the few patients described
with homozygous or compound mutations display a severe phenotype
characterized by combination of multiple paroxysmal neurological dis-
orders, severity and persistence of the paroxysmal attacks, occurrence
of unusually prolonged ataxia episodes, presence of intractable epilepsy
associated with sign of encephalopathy (Delcourt et al., 2015; Labate et
al., 2012). The motor/epileptic phenotype of homozygous PRRT2 KO
mice in response to environmental stimuli is reminiscent of the severe
manifestations experienced by homozygous patients, although no
spontaneous seizures or marked cognitive impairments were observed.4.4. How are PRRT2-linked motor paroxysms generated?
Acute silencing of PRRT2 in wild type neurons induced a sharp de-
crease of evoked synchronous transmission due to the loss of Ca2+ sen-
sitivity of the release process. The substantial absence of gross
behavioral alterations under basal conditions suggests that compensa-
torymechanisms duringdevelopmentmight have come into play. How-
ever, the transition between the basal state and paroxysmal activity
implies that the chronic absence of PRRT2 induces functional abnormal-
ities in specific networks due to developmental defects or network
instability.
PRRT2 KOmice displayed a specifically altered plasticity at the PF-PC
synapses of the cerebellum, in the absence of major changes in basalin PCs fromWT and PRRT2 KOmice in the presence of TTX. Themean (±SEM) amplitude
rs) mice. N= 9 and 11 neurons fromWT (3 mice) and PRRT2 KO (3mice), respectively. B.
se to single (top) or paired (bottom) stimuli. Right:Mean (±SEM) eEPSC amplitude (top)
for WT (open bar/symbol) and PRRT2 KO (black bar/symbol) mice. C. PRRT2 knockdown
ues of eEPSC amplitude showing the time course of synaptic facilitation and depression in
z. In the insets, representative traces showing synchronous EPSCs evoked by the tetanic
0 (middle) and 40 (bottom) Hz plotted as means (±SEM) against the stimulus number.
mpared (10 Hz: 0.006 ± 0.001 and 0.010 ± 0.001, p b 0.01; 20 Hz: 0.011 ± 0.002 and
T2 KO neurons, respectively). *p b 0.05; **p b 0.01, two-tailed unpaired Student's t-test.
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quency transmission between granule cells, expressing very high
PRRT2 levels, and the PC output of the cerebellar cortex. Indeed, ataxia
and motor coordination problems can result from dysfunctions in
short- and long-term plasticity properties at the PF-PC synapse, in
which the fine-tuning of sensorimotor information in response to
changing behavioral needs is altered (Becker, 2014).
Synaptic transmission in the DG of the hippocampus was also inves-
tigated as DG is one of the forebrain areas with the highest PRRT2 ex-
pression and is known to filter sensory information entering the
hippocampus from the cortex. However, synaptic transmission in the
DG was not markedly altered except for an increased frequency of
mEPSCs,mirrored by an increased density of VGLUT1-positive synapses,
and a likely compensatory increase in the strength of evoked GABAergic
transmission.
4.5. Are there shared mechanisms for motor paroxysms?
Recurrent neurological dysfunctions present in several disorders in-
cluding epilepsy, episodic ataxia and hemiplegic migraine are thought
to involve similar pathogenetic mechanisms in which a trigger induces
an attack in subjects that are otherwise normal. Mutations in PRRT2,
PNKD, P/Q-type Ca2+ (Cav2.1) and TRPC3 channels have all been asso-
ciatedwith a variety of paroxysmal disorders inman andmouse, such as
kinesigenic dyskinesia and/or coreoathetosis (Ebrahimi-Fakhari et al.,
2015), non-kinesigenic dyskinesia (Shen et al., 2015), tottering or lethar-
gic-type of dyskinesia (Khan and Jinnah, 2002; Matsushita et al., 2002)
andmoonwalker-type of cerebellar ataxia (Becker et al., 2009). The atax-
ic PNKDKOmouse is particularly interesting, as it involves themutation
of a presynaptic protein interacting with RIM1 that, similarly to PRRT2,
is highly expressed in the cerebellum and participates in the post-
docking steps of exocytosis (Shen et al., 2015).
From a behavioral standpoint, the paroxysmal dyskinesia tottering,
lethargic and moonwalker models share similar aspects with the PRRT2
KO mouse. Tottering mice exhibit stereotyped attacks of dystonia trig-
gered by stress, caffeine or ethanol (Raike et al., 2013) and bear muta-
tions in Cav2.1 (P/Q-type) that in human are associated with episodic
ataxia and hemiplegic migraine, two pathologies also linked to PRRT2
mutations. Lethargicmice, bearing mutations in the Cav2.1 β4 auxiliary
subunit, also display absence epilepsy and attacks ofmotor disability. Fi-
nally, moonwalker mice, exhibiting the most similar phenotype to
PRRT2 KO mice, with backward locomotion and motor coordination
deficits, bear a mutation in the non-selective cation channel TRPC3
that, similarly to PRRT2, is highly expressed in the cerebellum (Becker,
2014; Becker et al., 2009).
When the causative genes of paroxysmal motor dysfunctions in
these mouse models are considered, two functional groups of affected
genes emerge: (i) one group of Ca2+ channels; (ii) another group of
presynaptic proteins (PRRT2, PNKD) involved in interactions with pre-
synaptic Ca2+ channels or regulating the Ca2+ sensitivity of exocytosis
(Shen et al., 2015; Valente et al., 2016). Although the former disorders
can be considered channelopathies and the latter synaptopathies, it is
possible that in both cases presynaptic Ca2+ signaling and Ca2+-depen-
dent neurotransmitter release are severely disturbed, leading to net-
work instability/hyperexcitability and thereby to paroxysmal disorders.
In conclusion, this study describes for the first time the phenotype of
KOmice for PRRT2 and shows that its loss-of-function recapitulates the
human phenotype in terms of episodic disturbances in motor coordina-
tion and paroxysmal dyskinesias, suggesting that PRRT2 plays a critical
role in the development of cortical connectivity and functional stability
of neuronal networks. From these considerations, the PRRT2 KOmouse
emerges as a promising experimental model and as a starting point to
identify therapeutic targets and refine specific drug approaches of
PRRT2-related diseases.
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